Study Selection The trials we included met the following criteria: (1) RCTs that compared GLP-1 receptor agonist with a placebo or active control (other antidiabetic drugs or insulin), (2) patients with type 2 diabetes, type 1 diabetes, prediabetes, overweight or obesity, (3) with durations of at least 24 weeks, and (4) reported the occurrence of at least one case of various thyroid disorders as adverse events
Despite this lower bioavailability, clinical trials have shown that properly dosed oral GLP-1 medications can achieve similar effectiveness to injectable versions for both blood sugar control and weight loss
To learn more about how I help my clients to achieve their health goals, please visit my Functional Medicine page
Watch for Common Nutrition Mistakes Cleveland Clinic reports that eating too few calories for extended periods can reduce available energy and contribute to fatigue. Signs commonly discussed in relation to low intake include feeling tired, difficulty completing workouts, or slower recovery